Superior Drug Delivery Systems, Inc.            

Superior's Symbol - a Superior Researcher

 


Superior Drug Delivery Systems, Inc.

Our drug delivery systems work with your body's natural hormones to get the drug to its target to achieve its maximum efficacy. We use the natural properties of insulin, which delivers glucose into your red blood cells. Insulin has a special ability to cross through the cell wall that protects and shapes your red blood cells. We have isolated the specific "key" to this ability, and now produce it in the lab. We attach this 'key' to certain medicines to deliver them directly into the red blood cell.

After our successful IPO in 1998, we had the resources to begin moving our Insulin Delivery System to Phase I trials. You may recall reading news articles in April 2000 about the simultaneous revolutions in science (mapping the DNA sequence and our Insulin Delivery System). After all the promise, unfortunately, the FDA issued a Refusal To File (RTF) letter. While they cited no safety issues, they explained that the delivery system was too revolutionary, and it required extensive further testing. Unfortunately, our creditors did not have the patience for this, and we were forced into Chapter 11 bankruptcy while we continued to perform research and work on the IDS. We expect to emerge from bankruptcy within the next few weeks, and once the bankruptcy court accepts our Plan of Reorganization, the sky is the limit for our share price. If you would like to invest at our current stock price, click here to determine if there is still time.

Currently, our research is at the end of 'Phase II' (100-300 volunteers to test the safety and efficacy of the medicines). We have completed and submitted the data that the FDA requires for Phase III testing, and we are awaiting their response. Because we again found no evidence of any safety hazards with this delivery system (the red blood cells remained equally sensitive to insulin carrying glucose throughout the entire test period) we expect to move to Phase III testing in the next several weeks. Phase III testing normally takes up to 3 years, however, the FDA has announced that it will "Fast Track" this product, cutting the time to under 7 months.

Ready to get in on a fabulous deal? Click here to invest!

 

 

 

Copyright ©2002 Superior Drug Delivery Systems, Inc. All rights reserved.

The product information provided in this site is intended for only for residents of the United States. The products herein may have different product labeling in different countries.